Zevra therapeutics reports first quarter 2024 financial results and corporate updates

Full commercial launch of olpruva at the end of january 2024, with market access growing to ~ 75% of covered lives as of may 1, 2024
ZVRA Ratings Summary
ZVRA Quant Ranking